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Abstract
The current Covid-19 pandemic has already had a definite impact on the daily life of many people worldwide. It has been proposed
that people with preexisting medical conditions will be harder hit by the pandemic and the subsequent measures to contain the
spread of the disease. In this questionnaire-based, observational study, we aimed to assess the impact of the pandemic on patients
with a chronic pain disorder, who are treated at a tertiary multidisciplinary pain center.
Participants rated the impact of the pandemic on their chronic pain disorder using a self-designed questionnaire. Also, participants
filled out the regular follow-up questionnaire to assess a chronic pain disorder measuring among other parameters pain intensity,
symptoms of depression, anxiety, stress, and pain-related quality of life.
Of 136 eligible patients who presented to our pain center between May 5th and July 17th, 112 agreed to participate in the study
(82.4%). Eighty two participants (73.2%) reported a deterioration of the pain disorder using the self-designed questionnaire. The
more robust parameters of the regular follow-up questionnaire showed no relevant changes compared to data collected before the
pandemic. We were not able to detect any demographic and medical parameters that were clinically relevantly associated with a
higher impact of the pandemic.
We conclude that a chronic pain disorder is a relatively stable disease that does not change significantly due to external factors, like
the Covid-19 pandemic, even if the subjective impact is perceived to be high.
Abbreviations: MCS = Mental Composite Summary, PCS = Physical Composite Summary, PI = Von-Korff graduation of pain
intensity.
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1. Introduction
At the beginning of the COVID-19 pandemic, most countries
focused on treating patients who contracted COVID-19 and, at
the same time, tried to prevent the spread of the disease, using
different methods of prevention. Most countries imposed
measures that affected daily life, such as restricting person-to-
person contacts up to issuing home quarantine orders.[1,2] Health
providers prepared for a surge of COVID-19 patients by
postponing non-emergency treatments [3] and allocating person-
nel from non-emergency specialties to other areas, for example,
intensive care medicine.[4] Also, patients refrained from going to
hospitals, even in medical emergencies, because of the fear of
getting infected with COVID-19.[5] Due to these reasons, it was
recognized early on, that the COVID-19 pandemic indirectly
caused a health crisis among other patients as well, for example,
oncological patients,[6] and patients with other chronic dis-
eases.[7] The dangers of social distancing and loneliness have been
described for patients suffering from preexisting mental ill-
nesses,[8] and for previously healthy individuals as well.[9] The
impact of the COVID-19 pandemic on chronic pain has been
addressed: Recommendations for the care of patients suffering
from chronic non-malignant pain have been proposed.[10,11]
Some authors see the potential for an exacerbation of preexisting
chronic pain disorders and an increase in the number of people
with chronic pain after the pandemic.[12]
In our interdisciplinary pain center, we had to stop our
inpatient multimodal pain treatment program at the end
of March. We were also unable to see patients in our
outpatient clinic in person from the end of March until the
beginning of May. At that point, we started a stepwise
reopening of the outpatient clinic over 2 months, with a full
reopening in July.
This study aimed to examine the short-term impact of the
COVID-19 pandemic and the associated measures on patients
with chronic non-malignant pain. Also, we tried to identify
predisposing factors for a higher impact of the pandemic in these
patients.
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Our outpatient clinic was closed fromMarch 24th until May 4th
2020 (shutdown period). Due to our medical staff being allocated
to other clinical areas, we were not able to offer tale health
services. During May, we slowly resumed in-person patient
contacts, increasing the number of patients seen in June until the
full opening of our clinic on July 1st. We asked all patients who
had had previous visits to our clinic before March 24th and who
presented to our clinic fromMay 5th until July 17th to participate
in our study. Patients younger than 18years and patients without
sufficient knowledge of the German language were excluded from
participation. All patients gave written informed consent. The
study was approved by the ethics committee of the University of
Regensburg (20-1772_1-101).
2.2. Design/data collection
All participants were asked to fill out 2 questionnaires. The first
questionnaire was self-designed to assess the subjective impact of
the pandemic by posing nine questions (Impact Q). Answers to
questions 1 to 7 were formulated in a Likert scale type with a five-
point agreement scale, questions 8 and 9 could be answered with
yes or no (Table 1). To assess the subjective overall impact of the
pandemic, we calculated a sum score from the answers to
questions 1 to 7. We scored the individual answer items on the
Likert scale from 1 to 5 (e.g., for Q1, 1=much higher, 2= rather
higher, 3=equal, 4= rather lower, 5=much lower) resulting in a
potential sum score range from 7 to 35.
The second questionnaire was the follow-up questionnaire
recommended by the German Pain Society (Deutsche Schmerz-
gesellschaft e.V.) to use in follow-up visits of patients with
chronic pain. It consists of 6 sub-tests that measure different
aspects of a chronic pain disorder (Table 2). We regularly ask our
patients to fill out this questionnaire on each of their follow-up
visits.
The results of the 2 questionnaires were entered into an Excel
spreadsheet (Excel 2016, Microsoft, Redmond, WA) and then
linked to the results of the follow-up questionnaire that were
available from the last visit of the patient before the shutdown
period of our clinic. Participants’ demographic and medical data
were collected from their medical records.
2.3. Data analysis
We used IBM SPSS Statistics 26 (IBM, Armonk, NY) for data
analysis. We compared the demographic and medical informa-
tion of participants and non-participants with a t-test, a Mann–
Whitney test, and a Chi-Squared test where appropriate. The
results of the follow-up questionnaires before the shutdown
period (preQ) to the results of the follow-up questionnaires after
the shutdown (postQ) were compared using a paired t-test. To
examine the association of the participants’ demographic and
medical parameters and the sum score (ImpactQ) and the
differences of certain sub-tests of the preQ/postQ, we performed
a t-test for nominal, a one-way ANOVA for ordinal data, and
calculated Pearson correlation coefficients for interval data. For
all tests, a P value <.05 was defined as statistically significant.
3. Results
Participation is shown in Figure 1. Two hundred nine patients
presented to our outpatient pain clinic betweenMay 5th and July
17th. One hundred thirty six patients were eligible for
participation. Of these, 112 consented to participate in the
study (82.4%). These patients answered the ImpactQ and the
postQ. Participants and non-participants did not differ statisti-
cally significant in most of their demographic and medical
parameters (Table 3). For 98 of the participants, preQ
questionnaires were available from previous visits (87.5%).
Scoring the answer items on the Likert scale from 1–5 (e.g., for
Q1, 1=much higher, 2= rather higher, 3=equal, 4= rather
lower, 5=much lower) we found that the mean of all answers for
Q1-Q7 was below 3 (Table 4). When calculating the sum scores
of Q1-Q7, 82 participants (73.2%) scored less than 21 points
(result if all items had been rated as unchanged), 25 (22.3%)
scored 21 points, and 5 (4.5%) more than 21 points (Fig. 2). The
mean sum score was 17.3 (SD 3.9). One patient reported that he
had been tested positive for the novel coronavirus (Q8), and 10
had close relatives or acquaintances who had tested positive (Q9).
Comparing the preQ and postQ results, we observed only small
changes in all sub-tests, none of which reached a level of statistical
significance (Table 5). We examined the association of the
participants’ demographic and medical parameters with the sum
score of the Impact Q and the differences of the sub-tests Von-
Korff graduation of pain intensity (PI), Physical Composite
Summary (PCS), and Mental Composite Summary (MCS) from
Table 1
Questionnaire to assess the impact of the pandemic (ImpactQ).
Item Question text Possible answers
Q1 During the pandemic, I felt the intensity of my pain to be ... much higher - rather higher - equal - rather lower - much lower
Q2 During the pandemic, my mood was ... much worse - rather worse - equal - rather better - much better
Q3 During the pandemic, my pain treatment was generally ... much worse - rather worse - equal - rather better - much better
Q4 During the pandemic, my relationships with other people were ... much worse - rather worse - equal - rather better - much better
Q5 The experience of the pandemic makes accepting my pain disorder ... much harder - rather harder - equal - rather easier - much easier
Q6 Because of the experience of the pandemic, the importance of my
pain disorder for my life has ...
much increased – rather increased – not changed – rather decreased
– much decreased
Q7 Due to the effects of the pandemic, I suspect that the future my pain
disorder will be ...
much worse - rather worse - equal - rather better - much better
Q8 Have you tested positive for the novel coronavirus yourself? yes - no
Q9 Has anyone in your close acquaintance and / or family tested positive
for the novel coronavirus?
yes - no
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Table 2
Content of the follow-up questionnaire.
Name of sub-test (Abbreviation) Measured aspect/Scoring Reference
Von-Korff graduation of pain intensity (PI) Measures pain intensity. Mean of current, average and highest pain intensity, each rated on an 11-point
scale (0–10) multiplied by 10, resulting in a number from 0–100 (0=no pain, 100=highest pain
intensity).
[31]
Von-Korff graduation of pain-related disability (PD) Measures pain-related disability. Mean of impairment in daily life, leisure activities, and work ability, each
rated on an 11-point scale (0 – 10), multiplied with 10, resulting in a number from 0–100 (0=no
disability, 100=highest disability).
[31]
Pain Descriptor List (SBL) Measures the affective component of pain. Patients rate how four adjectives describing the affective
component fit their pain sensation on a 4-point scale (0–3), resulting in a sum of 0–12 (0=no affective
component, 12=high affective component).
[32]
Marburg Questionnaire (FW7) Measures subjective well-being. Patients rate their affirmation of seven statements concerning well-being on
a 6-point scale (0–5), resulting in a sum of 0–35 (0=no subjective well-being, 35=highest subjective
well-being).
[33]
Veterans RAND 12 Item Health Survey (VR-12) Measures health-related quality of life. Patients rate 12 items. Scores for physical and psychological well-
being are calculated (Physical Composite Summary PCS, Mental Composite Summary MCS). Higher
scores indicate higher well-being.
[34]
Depression Anxiety Stress Scale (DASS) Measures symptoms of depression (DASS-D), anxiety (DASS-A), and stress (DASS-S). Patients rate their
affirmation of twenty one statements with seven statements concerning each subscale on a 4-point scale
(0–3), resulting in a sum score of 0–21 for each subscale (0=no symptoms, 21=high symptom-load)
[35]
Figure 1. Flow diagram of participation.
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the preQ and postQ. We found 3 statistically significant
associations (Table 6). Participants taking opioid medications
had a mean reduction of PI of 4.3 points from preQ to postQ,
while participants without opioid medication had an increase of
PI of 4.5 points. Education at the university level was associated
with an increase of MCS of 5.7 points, education on high school
level with a reduction of 0.5 points. Participants living in a
household with underaged children showed an increase in PCS of
4.0 points, those living without underaged children had a
reduction of 1.4 points.
4. Discussion
In this study, we aimed to determine the short-term impact of the
COVID-19 pandemic on patients with a chronic pain disorder.
There is no validated tool for measuring the impact of a health crisis
Table 4
Results of the ImpactQ.
Rating, N (%)
∗
Question (n) much higher (1) rather higher (2) equal (3) rather lower (4) much lower (5) Mean† (SD)
During the pandemic, I felt the intensity of my pain to
be ... (112)
11 (9.8%) 38 (33.9%) 59 (52.7%) 3 (2.7%) 1 (0.9%) 2.51 (0.747)
much worse (1) rather worse (2) equal (3) rather better (4) much better (5)
During the pandemic, my mood was ... (112) 16 (14.3%) 50 (44.6%) 42 (37.5%) 2 (1.8%) 2 (1.8%) 2.32 (0.808)
During the pandemic, my pain treatment was
generally ... (109)
19 (17.4%) 35 (32.1%) 52 (47.7%) 3 (2.8&) 0 (0%) 2.36 (0.800)
During the pandemic, my relationships with other
people were ... (112)
21 (18.8%) 44 (39.3%) 41 (36.6%) 6 (5.4%) 0 (0%) 2.29 (0.832)
much harder (1) rather harder (2) equal (3) rather easier (4) much easier (5)
The experience of the pandemic makes accepting my
pain disorder ... (112)
5 (4.5%) 26 (23.2%) 76 (67.9%) 5 (4.5%) 0 (0%) 2.72 (0.618)
much increased (1) rather increased (2) equal (3) rather decreased (4) much decreased (5)
Because of the experience of the pandemic, the
importance of my pain disorder for my life has ...
(112)
10 (8.9%) 29 (25.9%) 69 (61.6%) 3 (2.7%) 1 (0.9%) 2.61 (0.727)
much worse (1) rather worse (2) equal (3) rather better (4) much better (5)
Due to the effects of the pandemic, I suspect that the
future my pain disorder will be ... (111)
11 (9.9%) 28 (20.6%) 70 (51.5%) 2 (1.5%) 0 (0%) 2.57 (0.696)
∗
The most frequently selected answer is shown in bold.
† Each rating on the Likert-Scale was awarded a score from 1 to 5. Mean was calculated from these scores.
Table 3
Demographic and medical parameters of all eligible patients.
Participants (N=112) Nonparticipants (N=24) Group comparison (P value)
∗
Age in years, mean (SD) 55.0 (13.1) 56.3 (17.1) .735
Gender
Female, N (%) 77 (69%) 17 (71%) .841
Male, N (%) 35 (31%) 7 (29%)
Years since onset of the pain disorder, mean (SD) 15.0 (12.4) 11.7 (11.7) .224
Years being treated at our tertiary pain center, mean (SD) 4.0 (3.8) 3.9 (3.0) .735
Additional psychiatric diagnosis, N (%)†
-Affective disorder 63 (56%) 8 (33%) .041
-Anxiety disorder 18 (16%) 3 (13%) .660
-Other 27 (24%) 5 (21%) .732
Opioid medication, N (%) 38 (34%) 8 (33%) .955
Previous intensive multidisciplinary pain treatment 62 (55%) 10 (42%) .223
Currently employed, N (%) 44 (39%) 9 (38%) .871
Highest education, N (%)
-No education 0 0 .226
-High school 99 (88%) 19 (79%)
-University 13 (12%) 5 (21%)
Lives with a partner, N (%) 75 (67%) 14 (58%) .420
Lives with under aged children, N (%) 22 (20%) 4 (17%) .737
Place of residence‡, N (%)
-City 30 (27%) 6 (25%) .494
-Town 23 (21%) 3 (13%)
-Rural 59 (53%) 15 (63%)
∗
Significant differences in BOLD.
†More than one diagnosis possible.
‡ City >100,000 inhabitants, Town 10,000–99,999 inhabitants, Rural <10,000 inhabitants, classification adapted from[36].
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on any group of patients, therefore we self-designed the ImpactQ.
Weunderstand this questionnaire as a generalmeasuring instrument
of the subjective impression of the pandemic on each individual.We
also evaluated whether the experience of the pandemic led to any
change in our follow-up questionnaire. While this questionnaire
does not cover all outcome domains that are currently discussed as
relevant for the assessment of chronic pain,[13] it has beenused inour
pain center for many years and is recommended for use by the
German Pain Society until further notice.
We were able to include 112 of 136 eligible patients in this
study. Considering the high participation rate, although there
was 1 statistically significant difference between participants and
non-participants, we assume that the participants are a
representative sample of our patients in general. The participants’
characteristics show similarities concerning age, gender preva-
lence, and duration of the chronic pain disorder to the patients of
other tertiary multidisciplinary pain centers.[14–16]
Looking at the results of the ImpactQ, the answers to itemsQ1-
Q7 all shift on average towards deterioration. The item Q4
(social relationships) was rated the lowest. The risk of losing
social contacts during the pandemic with a subsequent negative
impact on well-being has already been mentioned.[17] Also, the
availability of pain therapy was rated as rather worse. Although
not systematically analyzed, many patients mentioned the lack of
exercise therapy/physiotherapy as an important reason for an
increase in pain intensity. When dealing with the pandemic and
subsequent measures in the future, we feel that it would be
important to enable patients to continue exercise therapy/
physiotherapy, maybe even in a group under the strict following
of hygienic rules to sustain social contacts, especially since
physical activity has been shown to have a positive impact on
psychological health during the pandemic.[18] While the
construction of a sum score out of Likert scale items can be
viewed critically, some authors think this is possible if the single
items are rated equally and the distance between the single scores
is visualized with equal lengths (as we did in the ImpactQ).[19]
Almost 3/4 of participants had a sum score <21, indicating an
over-all shift in the direction of deterioration. Interestingly, this
Figure 2. Display of the distribution of sum scores of the ImpactQ.
Table 5
Comparison of preQ and postQ results for participants who had filled out both questionnaires
∗
.





PI (92) 63.4 (16.8) 64.9 (17.3) -1.5 .345
PD (89) 57.5 (20.4) 58.9 (23.1) -1.4 .478
SBL (98) 4.3 (3.6) 4.2 (3.7) 0.1 .795
FW7 (98) 13.6 (8.1) 13.8 (8.5) -0.2 .806
VR-12, PCS (98) 30.6 (8.8) 30.3 (9.4) 0.3 .722
VR-12, MCS (98) 33.5 (8.7) 33.7 (7.8) -0.2 .862
DASS-D (98) 8.7 (5.6) 8.7 (6.3) 0 .967
DASS-A (98) 6.4 (4.8) 6.3 (4.9) 0.1 .769
DASS-S (98) 10.4 (5.3) 10.1 (5.7) 0.3 .586
∗
Data given in mean (SD).
† PI = Von-Korff graduation of pain intensity, PD = Von-Korff graduation of pain related disability, SBL = Pain Descriptor List, FW7 = Marburg Questionnaire, VR-12 = Veterans RAND 12 Item Health Survey,
PCS = Physical Composite Summary, MCS = Mental Composite Summary, DASS = Depression Anxiety Stress Scale.
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deterioration was not evident in the differences between preQ and
postQ. The sub-tests of the follow-up questionnaire seem to be
more robust towards changes or adverse events than the
ImpactQ. Our study encompassed patients with a high degree
of chronification, typical for a tertiary pain center. We assume
that in these patients, the chronic pain disorder represents a
rather stable disease not easily influenced in its trajectory while at
the same time, the subjective impact of external factors is felt to be
high. A stable disease trajectory in terms of persistent pain
intensity levels over time has been shown in chronic pain patients
in previous studies,[20,21] complying with our results. In another
study, patients with fibromyalgia-like pain reported no relevant
changes after the 9/11 attacks in New York in 2002,[22]
suggesting that the effect of major events on individual health
might not be as high as expected.
We saw only a few patients with improved test results (either
ImpactQ or postQ/preQ difference). It seems that the pandemic
has not caused a positive change after adversity, as described by
some studies under different adverse events.[23] One could have
expected that the experience of the pandemic would shift
attention from personal problems (i.e., pain disorder) towards
greater social challenges (i.e., Covid-19 pandemic) and coping
thereof. We found no evidence for this mechanism in our study,
with only 5 participants feeling an increased acceptance of their
pain disorder (Q5) and 4 participants seeing less importance of
their pain disorder for their life (Q6).
The analysis of parameters associated with changes in selected
test results showed an inconclusive pattern. While some
parameters were associated with differences, the clinical
relevance is rather low. For example, the intake of opioid
medication led to a reduction of PI of 4.3 points on a 101-point
scale. While there is no established minimally clinically important
difference for PI, it can be deducted from other studies that it
should be at least 10 points.[24] Also, the changes in MCS and
PCS for participants with a university education (5.7 points
increase) and living with under aged children (4.0 points increase)
respectively barely reached the minimally clinically important
difference published for these components of the VR-12.[25]
We believe that based on these results, it is not justified to
identify any parameters as having a relevant association with the
impact of the pandemic in patients with a chronic pain disorder.
Consequently, they cannot be used to define populations at risk
of a higher negative impact of the pandemic. This differs from the
results of another study that had identified women, young people
and people living with preschool-aged children to be at risk of
developing future mental illnesses. [26]
There are some limitations in this study. The study has been
conducted at a single-center with a selected group of patients,
reducing the generalizability of the results. Also, the direct impact
of the pandemic on health systems worldwide has been very
different, with different closure times at different medical
institutions. We still feel that our results can be transferred to
other treatment facilities since the measures undertaken to reduce
the spread of Covid-19 were quite strict in our area and resemble
those of other regions. Since there is no validated tool to measure
the impact of a pandemic, we had to rely on a self-designed non-
validated questionnaire as other researchers have done as
well.[27,28] We felt that validated questionnaires to assess the
impact of a traumatic experience, as the Impact of Event Scale,[29]
were not useful for our purpose since they usually focus on the
symptoms of a posttraumatic stress disorder. We were not able to
form a control group since the ImpactQ and the preQ/postQ are
focused on patients with chronic pain and therefore not
applicable to a normal cohort. Finally, we only examined the
short-term impact of the Covid-19 pandemic. While most
patients experience symptoms close to traumatic events, some
patients have a delayed onset of symptoms.[30] To identify these
patients, repeated surveys at greater intervals would be necessary.
In conclusion, we could show that the short term impact of the
Covid-19 pandemic was rated as high by patients with a chronic
pain disorder on a subjective scale. At the same time, more robust
measuring tools for chronic pain showed a stable disease
trajectory. We were not able to identify demographic or medical
parameters that had a relevant association with the impact of the
pandemic. We think that to reduce the (subjective) impact of the
Covid-19 pandemic, treatment facilities should offer as much
Table 6













Gender .276 .793 .904 .908
Affective disorder .529 .931 .680 .373
Anxiety disorder .098 .052 .535 .893
Other psychiatric disorder .968 .203 .560 .972
Opioid medication .473 .009 .885 .705
Previous intensive multidisciplinary pain treatment .973 .163 .564 .154
Currently employed .161 .817 .161 .510
Highest education .983 .207 .284 .038
Lives with a partner .590 .971 .511 .817
Lives with under aged children .479 .207 .011 .514
Ordinal data (one-way ANOVA)
Place of residence .050 .128 .782 .550
Metric data (Pearson correlation coefficient)
Age .887 .848 .808 .785
Years since onset of the pain disorder .706 .646 .660 .534
Years being treated at our tertiary pain center .454 .695 .947 .144
∗
Statistically significant results in BOLD.
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therapeutic content and keep contact to the patients as possible
while maintaining safety measures to reduce the risk of infection.
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